• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为σ2受体配体的N-取代的9-氮杂双环[3.3.1]壬烷-3α-基氨基甲酸酯类似物的合成。

Synthesis of N-substituted 9-azabicyclo[3.3.1]nonan-3alpha-yl carbamate analogs as sigma2 receptor ligands.

作者信息

Vangveravong Suwanna, Xu Jinbin, Zeng Chenbo, Mach Robert H

机构信息

Division of Radiological Sciences, Washington University School of Medicine, Mallinckrodt Institute of Radiology, St. Louis, MO 63110, USA.

出版信息

Bioorg Med Chem. 2006 Oct 15;14(20):6988-97. doi: 10.1016/j.bmc.2006.06.028. Epub 2006 Jul 11.

DOI:10.1016/j.bmc.2006.06.028
PMID:16837201
Abstract

A series of N-substituted 9-azabicyclo[3.3.1]nonan-3alpha-yl phenylcarbamate analogs was prepared and their affinities for sigma (sigma(1) and sigma(2)) receptors were measured in vitro. The results of their structure-activity relationship study identified two new compounds, N-(9-(4-aminobutyl)-9-azabicyclo[3.3.1]nonan-3alpha-yl)-N'-(2-methoxy-5-methylphenyl)carbamate and N-(9-(6-aminohexyl)-9-azabicyclo[3.3.1]nonan-3alpha-yl)-N'-(2-methoxy-5-methylphenyl)carbamate, having a high affinity and selectivity for sigma(2) versus sigma(1) receptors. These compounds were also used in the preparation of biotinylated and fluorescent probes of the sigma(2) receptor.

摘要

制备了一系列N-取代的9-氮杂双环[3.3.1]壬烷-3α-基苯基氨基甲酸酯类似物,并在体外测定了它们对σ(σ1和σ2)受体的亲和力。它们的构效关系研究结果鉴定出两种新化合物,N-(9-(4-氨基丁基)-9-氮杂双环[3.3.1]壬烷-3α-基)-N'-(2-甲氧基-5-甲基苯基)氨基甲酸酯和N-(9-(6-氨基己基)-9-氮杂双环[3.3.1]壬烷-3α-基)-N'-(2-甲氧基-5-甲基苯基)氨基甲酸酯,对σ2受体相对于σ1受体具有高亲和力和选择性。这些化合物还用于制备σ2受体的生物素化和荧光探针。

相似文献

1
Synthesis of N-substituted 9-azabicyclo[3.3.1]nonan-3alpha-yl carbamate analogs as sigma2 receptor ligands.作为σ2受体配体的N-取代的9-氮杂双环[3.3.1]壬烷-3α-基氨基甲酸酯类似物的合成。
Bioorg Med Chem. 2006 Oct 15;14(20):6988-97. doi: 10.1016/j.bmc.2006.06.028. Epub 2006 Jul 11.
2
Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.氮杂三环辛烷 σ(sigma)受体配体的氧桥异构体:合成、体外结合和分子模拟。
Bioorg Med Chem Lett. 2010 Jan 1;20(1):145-8. doi: 10.1016/j.bmcl.2009.11.019. Epub 2009 Nov 12.
3
4-(tetralin-1-yl)- and 4-(naphthalen-1-yl)alkyl derivatives of 1-cyclohexylpiperazine as sigma receptor ligands with agonist sigma2 activity.1-环己基哌嗪的4-(四氢萘-1-基)-和4-(萘-1-基)烷基衍生物作为具有激动剂sigma2活性的σ受体配体。
J Med Chem. 2004 Apr 22;47(9):2308-17. doi: 10.1021/jm031026e.
4
Synthesis and quantitative structure-activity relationships of N-(1-benzylpiperidin-4-yl)phenylacetamides and related analogues as potent and selective sigma1 receptor ligands.N-(1-苄基哌啶-4-基)苯乙酰胺及相关类似物作为强效和选择性σ1受体配体的合成与定量构效关系
J Med Chem. 1998 Jun 18;41(13):2361-70. doi: 10.1021/jm980032l.
5
Exploring the importance of piperazine N-atoms for sigma(2) receptor affinity and activity in a series of analogs of 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28).探索哌嗪氮原子对1-环己基-4-[3-(5-甲氧基-1,2,3,4-四氢萘-1-基)丙基]哌嗪(PB28)系列类似物中σ(2)受体亲和力和活性的重要性。
J Med Chem. 2009 Dec 10;52(23):7817-28. doi: 10.1021/jm9007505.
6
Chiral, nonracemic (piperazin-2-yl)methanol derivatives with sigma-receptor affinity.具有σ受体亲和力的手性、非外消旋(哌嗪-2-基)甲醇衍生物
Bioorg Med Chem. 2004 Jun 15;12(12):3299-311. doi: 10.1016/j.bmc.2004.03.059.
7
Novel sigma receptor ligands: synthesis and biological profile.新型西格玛受体配体:合成与生物学特性
J Med Chem. 2007 Mar 8;50(5):951-61. doi: 10.1021/jm0611197. Epub 2007 Feb 13.
8
(+)-cis-N-ethyleneamino-N-normetazocine derivatives. Novel and selective sigma ligands with antagonist properties.(+)-顺式-N-乙烯氨基-N-去甲美沙酮衍生物。具有拮抗剂特性的新型选择性σ配体。
J Med Chem. 1998 May 7;41(10):1574-80. doi: 10.1021/jm970333f.
9
Synthesis and evaluation of tetrahydroindazole derivatives as sigma-2 receptor ligands.作为σ-2受体配体的四氢吲唑衍生物的合成与评价
Bioorg Med Chem. 2015 Apr 1;23(7):1463-71. doi: 10.1016/j.bmc.2015.02.012. Epub 2015 Feb 16.
10
7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (σ2) receptor ligands.7-氮杂双环[2.2.1]庚烷作为开发选择性σ2(σ2)受体配体的支架。
Bioorg Med Chem Lett. 2012 Jun 15;22(12):4059-63. doi: 10.1016/j.bmcl.2012.04.077. Epub 2012 Apr 30.

引用本文的文献

1
Exploration of Diazaspiro Cores as Piperazine Bioisosteres in the Development of σ2 Receptor Ligands.探索二氮杂螺[4.5]癸烷核心作为哌嗪生物等排体在σ2 受体配体开发中的应用。
Int J Mol Sci. 2022 Jul 27;23(15):8259. doi: 10.3390/ijms23158259.
2
σ Receptor and Its Role in Cancer with Focus on a MultiTarget Directed Ligand (MTDL) Approach.σ 受体及其在癌症中的作用,重点介绍一种多靶点定向配体 (MTDL) 方法。
Molecules. 2021 Jun 19;26(12):3743. doi: 10.3390/molecules26123743.
3
Recent Advances in the Development of Sigma Receptor Ligands as Cytotoxic Agents: A Medicinal Chemistry Perspective.
近年来,作为细胞毒剂的 sigma 受体配体的发展进展:药物化学视角。
J Med Chem. 2021 Jun 24;64(12):7926-7962. doi: 10.1021/acs.jmedchem.0c02265. Epub 2021 Jun 2.
4
Small-Molecule Modulators of Sigma1 and Sigma2/TMEM97 in the Context of Cancer: Foundational Concepts and Emerging Themes.癌症背景下西格玛1和西格玛2/TMEM97的小分子调节剂:基础概念与新出现的主题
Front Pharmacol. 2019 Oct 21;10:1141. doi: 10.3389/fphar.2019.01141. eCollection 2019.
5
Conjugation to the sigma-2 ligand SV119 overcomes uptake blockade and converts dm-Erastin into a potent pancreatic cancer therapeutic.与sigma-2配体SV119偶联可克服摄取障碍,并将dm-厄拉司丁转化为一种有效的胰腺癌治疗药物。
Oncotarget. 2016 Jun 7;7(23):33529-41. doi: 10.18632/oncotarget.9551.
6
The sigma-2 receptor as a therapeutic target for drug delivery in triple negative breast cancer.σ-2受体作为三阴性乳腺癌药物递送的治疗靶点。
Biochem Biophys Res Commun. 2015 Nov 27;467(4):1070-5. doi: 10.1016/j.bbrc.2015.09.157. Epub 2015 Oct 9.
7
Targeted pancreatic cancer therapy with the small molecule drug conjugate SW IV-134.使用小分子药物偶联物SW IV-134进行靶向胰腺癌治疗。
Mol Oncol. 2014 Jul;8(5):956-67. doi: 10.1016/j.molonc.2014.03.005. Epub 2014 Mar 26.
8
Using SV119-gold nanocage conjugates to eradicate cancer stem cells through a combination of photothermal and chemo therapies.利用SV119-金纳米笼偶联物通过光热疗法和化学疗法相结合的方式根除癌症干细胞。
Adv Healthc Mater. 2014 Aug;3(8):1283-91. doi: 10.1002/adhm.201400026. Epub 2014 Mar 26.
9
Conjugation to a SMAC mimetic potentiates sigma-2 ligand induced tumor cell death in ovarian cancer.与SMAC模拟物结合可增强sigma-2配体诱导的卵巢癌细胞死亡。
Mol Cancer. 2014 Mar 7;13:50. doi: 10.1186/1476-4598-13-50.
10
Functional assays to define agonists and antagonists of the sigma-2 receptor.用于定义σ-2受体激动剂和拮抗剂的功能测定。
Anal Biochem. 2014 Mar 1;448:68-74. doi: 10.1016/j.ab.2013.12.008. Epub 2013 Dec 12.